Electromed (ELMD) Competitors $25.12 +0.48 (+1.95%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$25.07 -0.05 (-0.20%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELMD vs. AXGN, CLPT, SIBN, BFLY, BVS, AVNS, ZIMV, KIDS, CBLL, and SMLRShould you be buying Electromed stock or one of its competitors? The main competitors of Electromed include AxoGen (AXGN), ClearPoint Neuro (CLPT), SiBone (SIBN), Butterfly Network (BFLY), Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), CeriBell (CBLL), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry. Electromed vs. Its Competitors AxoGen ClearPoint Neuro SiBone Butterfly Network Bioventus AVANOS MEDICAL ZimVie OrthoPediatrics CeriBell Semler Scientific AxoGen (NASDAQ:AXGN) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and valuation. Does the media refer more to AXGN or ELMD? In the previous week, AxoGen had 26 more articles in the media than Electromed. MarketBeat recorded 26 mentions for AxoGen and 0 mentions for Electromed. AxoGen's average media sentiment score of 0.48 beat Electromed's score of 0.00 indicating that AxoGen is being referred to more favorably in the media. Company Overall Sentiment AxoGen Neutral Electromed Neutral Do institutionals and insiders believe in AXGN or ELMD? 80.3% of AxoGen shares are owned by institutional investors. Comparatively, 40.8% of Electromed shares are owned by institutional investors. 2.8% of AxoGen shares are owned by insiders. Comparatively, 10.5% of Electromed shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts rate AXGN or ELMD? AxoGen currently has a consensus target price of $25.75, indicating a potential upside of 50.06%. Electromed has a consensus target price of $36.25, indicating a potential upside of 44.31%. Given AxoGen's higher probable upside, equities analysts clearly believe AxoGen is more favorable than Electromed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AxoGen 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60Electromed 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50 Is AXGN or ELMD more profitable? Electromed has a net margin of 11.34% compared to AxoGen's net margin of -2.29%. Electromed's return on equity of 15.71% beat AxoGen's return on equity.Company Net Margins Return on Equity Return on Assets AxoGen-2.29% -4.43% -2.34% Electromed 11.34%15.71%13.37% Which has higher valuation and earnings, AXGN or ELMD? Electromed has lower revenue, but higher earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxoGen$187.34M4.21-$9.96M-$0.10-171.60Electromed$64M3.29$5.15M$0.8429.90 Which has more risk and volatility, AXGN or ELMD? AxoGen has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500. Comparatively, Electromed has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500. SummaryElectromed beats AxoGen on 9 of the 17 factors compared between the two stocks. Get Electromed News Delivered to You Automatically Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELMD vs. The Competition Export to ExcelMetricElectromedElectromedical equipment IndustryMedical SectorNYSE ExchangeMarket Cap$206.39M$41.33M$6.09B$22.02BDividend YieldN/AN/A5.69%3.58%P/E Ratio33.493.7385.5629.86Price / Sales3.29209.65535.6564.35Price / Cash41.3641.3637.9224.43Price / Book4.932.7313.034.64Net Income$5.15M-$2.66M$3.30B$1.01B7 Day Performance1.62%0.83%4.35%0.44%1 Month Performance-5.60%4.67%9.50%3.13%1 Year Performance14.70%169.25%85.16%15.30% Electromed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELMDElectromed3.7821 of 5 stars$25.12+1.9%$36.25+44.3%+16.4%$206.39M$64M33.49160AXGNAxoGen3.1207 of 5 stars$17.16-4.0%$25.75+50.1%+26.1%$822.71M$187.34M-171.58450Analyst ForecastInsider TradeCLPTClearPoint Neuro0.7009 of 5 stars$26.59-2.9%$19.67-26.0%+154.7%$778.34M$31.39M-32.83110News CoverageAnalyst ForecastGap UpSIBNSiBone3.967 of 5 stars$14.49-0.1%$23.67+63.3%+13.1%$625.54M$167.18M-25.87350Analyst ForecastBFLYButterfly Network2.2601 of 5 stars$2.57+10.1%$3.00+17.0%+48.2%$586.56M$82.06M-9.16460Analyst ForecastOptions VolumeHigh Trading VolumeBVSBioventus1.2251 of 5 stars$6.79-3.3%N/AN/A$580.41M$573.28M14.041,200News CoverageAnalyst ForecastAVNSAVANOS MEDICAL2.0854 of 5 stars$11.57-1.9%N/A-49.0%$547.09M$687.80M-1.152,227Positive NewsZIMVZimVie1.3647 of 5 stars$18.92-0.1%$17.75-6.2%+21.8%$534.31M$449.75M-27.031,770Analyst ForecastKIDSOrthoPediatrics4.6342 of 5 stars$18.24-2.8%$34.14+87.2%-26.1%$470.63M$204.73M-10.19200Positive NewsAnalyst ForecastCBLLCeriBell2.3457 of 5 stars$12.57-0.6%$32.14+155.7%N/A$463.43M$65.44M-4.20N/ANews CoveragePositive NewsAnalyst ForecastInsider TradeSMLRSemler Scientific3.2893 of 5 stars$30.75+0.6%$74.25+141.5%+10.1%$452.43M$56.29M12.65120Analyst Forecast Related Companies and Tools Related Companies AXGN Competitors CLPT Competitors SIBN Competitors BFLY Competitors BVS Competitors AVNS Competitors ZIMV Competitors KIDS Competitors CBLL Competitors SMLR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ELMD) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Electromed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
